“…There are several mechanisms described for CUR derivatives to exercise their antiinflammatory activity. Liu et al (2015), reported that derivatives of CUR might alleviate airway inflammation in asthma through the Nrf2/HO-1 pathway. Other studies suggest that intranasal CUR (2.5 and 5.0 mg/ kg) regulates airway inflammation and airway obstruction by modulating cytokine levels (IL-4, IL-5, IFN-α, and TNF-α) and sPLA2 activity thereby inhibiting PGD 2 release and COX-2 expression (Kumari, Dash, & Singh, 2017;Masella, Di Benedetto, Varì, Filesi, & Giovannini, 2005;Subhashini, Chauhan, Dash, Paul, & Singh, 2016).…”